Trial Profile
An Observational Change-From-Baseline Evaluation of Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jun 2019
Price :
$35
*
At a glance
- Drugs Fluocinolone acetonide (Primary)
- Indications Uveitis
- Focus Therapeutic Use
- Sponsors Bausch & Lomb
- 20 Jun 2019 Status changed from not yet recruiting to completed.
- 11 May 2017 New trial record